Загрузка...
Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese
BACKGROUND: Whether rosiglitazone may affect the risk of non-melanoma skin cancer (NMSC) has not been investigated. METHODS: The reimbursement databases of all Taiwanese diabetic patients from 1996 to 2009 were retrieved from the National Health Insurance. An entry date was set at 1 January 2006 and...
Сохранить в:
| Опубликовано в: : | BMC Cancer |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4325941/ https://ncbi.nlm.nih.gov/pubmed/25655946 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1057-8 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|